Borrelial lymphocytoma cutis successfully treated with intralesional interferon-alpha-2A

dc.contributor.buuauthorAydoğan, Kenan
dc.contributor.buuauthorKaradoğan, S. Koran
dc.contributor.buuauthorAdım, Şaduman Balaban
dc.contributor.buuauthorTunalı, S.
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Dermatoloji Anabilim Dalı.tr_TR
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Patoloji Anabilim Dalı.tr_TR
dc.contributor.orcid0000-0002-0193-1128tr_TR
dc.contributor.researcheridAAH-6216-2021tr_TR
dc.contributor.scopusid9739755800tr_TR
dc.contributor.scopusid14047086200tr_TR
dc.contributor.scopusid14046617400tr_TR
dc.contributor.scopusid7004191748tr_TR
dc.date.accessioned2022-10-31T12:24:48Z
dc.date.available2022-10-31T12:24:48Z
dc.date.issued2006-09
dc.description.abstractScrofuloderma is increasingly being recognized as themost common form of cutaneous tuberculosis in adults.2,3It results from contiguous involvement of the skinoverlying tuberculosis in a deeper structure, mostcommonly a lymph node, bone, joint or epididymis.2 Bothour patients had cervical glands disease, which is the mostcommon site of involvement in scrofuloderma.4 It haspreviously been suggested that cervical gland involve-ment in tuberculosis may be related to consumption ofunpasteurized milk, leading to infection of the tonsils andsubsequently of the cervical lymph glands by Mycobacte-rium bovis.5 Our patients admitted to boiling milk beforeconsumption.The incidence of systemic tuberculosis in children withcutaneous tuberculosis has been noted to be between21.2%5 and 26%.6 The incidence of systemic involvementin adults with scrofuloderma has been found to be as highas 35%.2 There was no evidence of systemic tuberculosisin our patients. DNA polymerase chain reaction andBACTEC are the ideal techniques for the diagnosis ofcutaneous tubercular infections, but their availability andcosts are major limitations.6 We failed to find any reportin literature indicating a particular genetic predispositionto cutaneous tuberculosis. But the occurrence of a specificform of cutaneous tuberculosis in these siblings mayindicate activity of a common genetically mediatedimmunological pathway.en_US
dc.identifier.citationAydoğan, K. vd. (2006). ''Borrelial lymphocytoma cutis successfully treated with intralesional interferon-alpha-2A''. Journal of the European Academy of Dermatology and Venereology, 20(8), 1030-1032.en_US
dc.identifier.endpage1032tr_TR
dc.identifier.issn0926-9959
dc.identifier.issn1468-3083
dc.identifier.issue8tr_TR
dc.identifier.pubmed16922975tr_TR
dc.identifier.scopus2-s2.0-33747332480tr_TR
dc.identifier.startpage1030tr_TR
dc.identifier.urihttps://doi.org/10.1111/j.1468-3083.2006.01627.x
dc.identifier.urihttps://onlinelibrary.wiley.com/doi/10.1111/j.1468-3083.2006.01627.x
dc.identifier.urihttp://hdl.handle.net/11452/29277
dc.identifier.volume20tr_TR
dc.identifier.wos000239797200041tr_TR
dc.indexed.pubmedPubMeden_US
dc.indexed.scopusScopusen_US
dc.indexed.wosSCIEen_US
dc.language.isoenen_US
dc.publisherWileyen_US
dc.relation.journalJournal of the European Academy of Dermatology and Venereologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergitr_TR
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectDermatologyen_US
dc.subjectB-Cell lymphomaen_US
dc.subject.emtreePenicillin G.en_US
dc.subject.emtreeDoxycyclineen_US
dc.subject.emtreeB iymphocyte antigenen_US
dc.subject.emtreeAntibiotic agenten_US
dc.subject.emtreeAlpha2a interferonen_US
dc.subject.emtreeUnspecified side effecten_US
dc.subject.emtreeSkin noduleen_US
dc.subject.emtreeSkin lymphomaen_US
dc.subject.emtreeSerologyen_US
dc.subject.emtreePriority journalen_US
dc.subject.emtreePolymerase chain reactionen_US
dc.subject.emtreeNonhumanen_US
dc.subject.emtreeMaleen_US
dc.subject.emtreeLymphocytomaen_US
dc.subject.emtreeLymphocyteen_US
dc.subject.emtreeLow drug doseen_US
dc.subject.emtreeLetteren_US
dc.subject.emtreeHuman tissueen_US
dc.subject.emtreeHumanen_US
dc.subject.emtreeHistopathologyen_US
dc.subject.emtreeErythemaen_US
dc.subject.emtreeEnzyme linked immunosorbent assayen_US
dc.subject.emtreeDrug efficacyen_US
dc.subject.emtreeDNA sequenceen_US
dc.subject.emtreeDisease durationen_US
dc.subject.emtreeClinical protocolen_US
dc.subject.emtreeCase reporten_US
dc.subject.emtreeBorrelia burgdorferien_US
dc.subject.emtreeAntigen expressionen_US
dc.subject.emtreeAdulten_US
dc.subject.meshSkin diseases, bacterialen_US
dc.subject.meshPseudolymphomaen_US
dc.subject.meshMiddle ageden_US
dc.subject.meshMaleen_US
dc.subject.meshInterferon-alphaen_US
dc.subject.meshHumansen_US
dc.subject.meshEar, Externalen_US
dc.subject.meshBorrelia Infectionsen_US
dc.subject.scopusPseudolymphoma; Lymphomatoid Papulosis; Large Cell Lymphomaen_US
dc.subject.wosDermatologyen_US
dc.titleBorrelial lymphocytoma cutis successfully treated with intralesional interferon-alpha-2Aen_US
dc.typeLetter
dc.wos.quartileQ3en_US

Files

License bundle
Now showing 1 - 1 of 1
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: